Skip to content

Treatment of complex renal calculi

Clinical observation of single channel percutaneous nephrolithotomy combined with disposable electronic soft lens in the treatment of complex renal calculi

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13835301
Enrollment
40
Registered
2025-08-18
Start date
2023-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of patients with complex kidney stones Urological and Genital Diseases

Interventions

The patients are divided into observation group and control group by voluntary admission in advance. The observation group is treated with percutaneous renal single-channel disposable electronic soft
the control group is treated with traditional single percutaneous nephroscopy. Total treatment time: preoperative to discharge, followed up for 3 months after surgery

Sponsors

Hebei Yanda Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with complex renal calculi combined with medical history, signs and imaging findings 2. All patients with preoperative urinary tract infection received anti-infective treatment and were well controlled 3. Patients with abnormal blood pressure, blood glucose and electrolyte before operation returned to normal and maintained stable after active treatment by doctors 4. Patients with preoperative renal insufficiency or severe hydronephrosis had undergone one-stage nephrostomy 5. The patients were able to accept the hospitalization expenses of the double-mirror combination, and the willingness to operate was strong. All patients signed the informed consent 6. The case data were complete and the examination was perfect

Exclusion criteria

Exclusion criteria: 1. There were systemic hemorrhagic diseases, and the coagulation function had not been corrected 2. Long-term use of anticoagulant drugs such as aspirin, warfarin, preoperative non withdrawal for more than 1 week 3. With severe heart and lung disease, can not tolerate surgery and anesthesia 4. Renal malignant tumor, renal tuberculosis, pelvic ectopic kidney, polycystic kidney and severe renal prolapse were found before operation 5. The presence of severe joint or spinal deformity affects the placement of surgical position 6. Extremely obese, the skin-kidney distance value was too large, affecting the establishment of percutaneous renal working channel 7. Pregnant patients

Design outcomes

Primary

MeasureTime frame
Stone clearance rate is measured using non-contrast computed tomography (CT) at 24 hours post-procedure

Secondary

MeasureTime frame
1. Stone clearance rate is measured using non-contrast computed tomography (CT) at 3 months post-operation 2. Operation time is measured using intraoperative surgical records at the time of surgery 3. Intraoperative blood loss is measured using surgical suction volume and gauze weight at the time of surgery 4. Hospitalization time is measured using patient discharge records from admission to discharge 5. Postoperative complications are measured using the Clavien-Dindo classification at ... 6. Quality of life is measured using the Generic Quality of Life Inventory-74 (GQOLI-74) at baseline and 1 month post-surgery 7. Inflammatory response is measured using serum C-reactive protein (CRP) levels at 24 hours before surgery (T0), end of anesthesia (T1), 2 hours after surgery (T2), 12 hours after surgery (T3), 24 hours after surgery (T4), and 48 hours after surgery (T5) 8. Renal function is measured using serum cystatin C levels at baseline (before surgery), 2 hours after surgery, 12 hours after surgery, 24 hours after surgery, 48 hours after surgery, and 72 hours after surgery

Countries

China

Contacts

Public ContactYunbo Yang
Yangyunbo1266@163.com+86- 18810248916

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026